Featured News
OCT 2025
InterAx Biotech AG appoints Andrew Roberts as Chief Executive Officer. Seasoned drug development and portfolio strategy leader to fully leverage…
FEB 2024
InterAx Biotech unveils breakthroughs by identifying novel cellular modes of action unlocking the rational design of superior drugs for multiple…
NOV 2023
InterAx Biotech announces being the recipient of a highly competitive European grant to fund drug development and reports financing highlights.…